Strategy
Portfolio
People
Careers
April 11, 2018
6-month liver disease data reinforces CymaBay’s phase 3 move
Back
Portfolio News
Next
Back
Blog
Next
News
Blog
Foresite Labs
Contact Us
Home
Strategy
Portfolio
People
Careers
News
Blog
Foresite Labs
Contact
Investor Login
Terms
Privacy Policy
©2022 Foresite Capital Management, LLC
Site by Goodlab